Contraindicated in patients with a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia Syndromes (MEN 2) Consult your healthcare provider if you have a history of pancreatitis, as the medication may increase risk Serious side effects may involve hypoglycemia, kidney issues, or allergic reactions 1,5 Not suitable for individuals with type 1 diabetes or diabetic ketoacidosis Medication interactions may occur with those on insulin, oral diabetes medications, oral contraceptives, and blood thinners
Quality Assurance and Manufacturing Standards The 10mL vial sold here is produced in a US facility that operates under cGMP-aligned quality controls
Compounded Semaglutide : Previously used during shortages, now discontinued and not FDA-approved
Gastrointestinal adverse effects represent the most common tolerability concerns with GLP-1 receptor agonists, occurring in 2050% of patients
If it is absorbed well, it could offer similar benefits to injectable tirzepatide